These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 11562617)

  • 1. Maternal and infant use of erythromycin and other macrolide antibiotics as risk factors for infantile hypertrophic pyloric stenosis.
    Mahon BE; Rosenman MB; Kleiman MB
    J Pediatr; 2001 Sep; 139(3):380-4. PubMed ID: 11562617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertrophic pyloric stenosis in infants following pertussis prophylaxis with erythromycin--Knoxville, Tennessee, 1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Dec; 48(49):1117-20. PubMed ID: 10634345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal prescription of macrolide antibiotics and infantile hypertrophic pyloric stenosis.
    Cooper WO; Ray WA; Griffin MR
    Obstet Gynecol; 2002 Jul; 100(1):101-6. PubMed ID: 12100810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of erythromycin and infantile hypertrophic pyloric stenosis: causal or coincidental?
    Hauben M; Amsden GW
    Drug Saf; 2002; 25(13):929-42. PubMed ID: 12381214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromcyin: a case review and cohort study.
    Honein MA; Paulozzi LJ; Himelright IM; Lee B; Cragan JD; Patterson L; Correa A; Hall S; Erickson JD
    Lancet; 1999 Dec 18-25; 354(9196):2101-5. PubMed ID: 10609814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-natal erythromycin exposure and risk of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis.
    Murchison L; De Coppi P; Eaton S
    Pediatr Surg Int; 2016 Dec; 32(12):1147-1152. PubMed ID: 27655365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between exposure to macrolides and the development of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis.
    Abdellatif M; Ghozy S; Kamel MG; Elawady SS; Ghorab MME; Attia AW; Le Huyen TT; Duy DTV; Hirayama K; Huy NT
    Eur J Pediatr; 2019 Mar; 178(3):301-314. PubMed ID: 30470884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Very early exposure to erythromycin and infantile hypertrophic pyloric stenosis.
    Cooper WO; Griffin MR; Arbogast P; Hickson GB; Gautam S; Ray WA
    Arch Pediatr Adolesc Med; 2002 Jul; 156(7):647-50. PubMed ID: 12090829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azithromycin in early infancy and pyloric stenosis.
    Eberly MD; Eide MB; Thompson JL; Nylund CM
    Pediatrics; 2015 Mar; 135(3):483-8. PubMed ID: 25687145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral erythromycin prophylaxis vs watchful waiting in caring for newborns exposed to Chlamydia trachomatis.
    Rosenman MB; Mahon BE; Downs SM; Kleiman MB
    Arch Pediatr Adolesc Med; 2003 Jun; 157(6):565-71. PubMed ID: 12796237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of macrolides in mother and child and risk of infantile hypertrophic pyloric stenosis: nationwide cohort study.
    Lund M; Pasternak B; Davidsen RB; Feenstra B; Krogh C; Diaz LJ; Wohlfahrt J; Melbye M
    BMJ; 2014 Mar; 348():g1908. PubMed ID: 24618148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Erythromycin and hypertrophic stenosis of the pylorus].
    Oliva Rodríguez-Pastor S; García Martín FJ; Milano Manso G
    An Esp Pediatr; 2001 Mar; 54(3):318. PubMed ID: 11262265
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypertrophic pyloric stenosis caused by erythromycin.
    Hoey J
    CMAJ; 2000 Apr; 162(8):1198. PubMed ID: 10789643
    [No Abstract]   [Full Text] [Related]  

  • 14. Infantile hypertrophic pyloric stenosis: a study of feeding practices and other possible causes.
    Habbick BF; Khanna C; To T
    CMAJ; 1989 Feb; 140(4):401-4. PubMed ID: 2914261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypertrophic pyloric stenosis in infants. A retrospective study of cases observed in the years 1970-1990].
    Ceccarelli M; Villirillo A; Assanta N; Balsano L; Chiaravalloti G
    Pediatr Med Chir; 1992; 14(4):441-3. PubMed ID: 1461785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infantile hypertrophic pyloric stenosis: maternal diabetes and perinatal exposure to non-macrolide antibiotics.
    Cohen Elias S; Yarza S; Yerushalmi B; Shany E; Marks KA
    J Perinatol; 2023 Apr; 43(4):465-469. PubMed ID: 36702873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A question that won't go away.
    Sondheimer JM
    J Pediatr Gastroenterol Nutr; 2002 Feb; 34(2):241. PubMed ID: 11865812
    [No Abstract]   [Full Text] [Related]  

  • 18. Isolated hypertrophic pyloric stenosis and perinatal factors.
    Bianca S; Barbagallo MA; Ingegnosi C; Ettore G
    Genet Couns; 2003; 14(1):101-3. PubMed ID: 12725594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety of macrolides during lactation.
    Goldstein LH; Berlin M; Tsur L; Bortnik O; Binyamini L; Berkovitch M
    Breastfeed Med; 2009 Dec; 4(4):197-200. PubMed ID: 19366316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complications of pyloromyotomy for infantile hypertrophic pyloric stenosis.
    Hulka F; Harrison MW; Campbell TJ; Campbell JR
    Am J Surg; 1997 May; 173(5):450-2. PubMed ID: 9168087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.